- Open Access
Models in biology: lessons from modeling regulation of the eukaryotic cell cycle
© Tyson and Novák. 2015
- Published: 1 July 2015
In this essay we illustrate some general principles of mathematical modeling in biology by our experiences in studying the molecular regulatory network underlying eukaryotic cell division. We discuss how and why the models moved from simple, parsimonious cartoons to more complex, detailed mechanisms with many kinetic parameters. We describe how the mature models made surprising and informative predictions about the control system that were later confirmed experimentally. Along the way, we comment on the ‘parameter estimation problem’ and conclude with an appeal for a greater role for mathematical models in molecular cell biology.
- Mathematical models
- Mitosis-promoting factor
- Cell cycle checkpoints
- Regulated kinases
- Regulated phosphatases
- Regulated proteolysis
Jeremy Gunawardena  opened this series of review articles (on ‘models in biology’) with a quote from Nobel Laureate James Black, who described mathematical models as "accurate descriptions of our pathetic thinking about nature". Black, who made skilful use of mathematical models on the road to discovering antagonists of β-adrenergic receptors, was certainly not equating mathematical models with ‘pathetic thinking’ (as some people believe) but rather suggesting that mathematical models could be useful in turning our provisional ideas about molecular biology into real knowledge about living cells. Black saw three essential roles for models in biology: to expose assumptions, to define expectations, and to devise new tests. Our purpose in this review is to illustrate these principles by our experiences in modeling the control of mitosis in eukaryotic cells. We structure our review around subheadings derived from some cogent observations by Gunawardena (slightly paraphrased) about the art of building mathematical models in biology .
We focus in this review on the molecular mechanisms controlling entry into and exit from mitosis (M phase) in the natural cell cycles of frog embryos and fission yeast cells and in the artificial mitotic cycles exhibited by frog egg extracts. Because our focus is on certain principles of model building rather than a comprehensive description of cell cycle controls, we will not discuss the mechanisms controlling commitment of cells to DNA replication (S phase). Following an ancient tradition of cell biologists, we refer to G1, S and G2 phases of the cell cycle simply as ‘interphase’.
To describe the role of mathematical modeling in this endeavor, we start by summarizing the relevant knowledge — in 1990 — of the physiology and biochemistry of M-phase controls in frog eggs and fission yeast cells. Our description is based loosely on review articles of the time by Murray and Kirschner  and by Nurse .
Immature frog oocytes, which are arrested in G2 phase of meiosis I, can be induced by progesterone to proceed through meiosis I and arrest again in metaphase of meiosis II. These mature oocytes are ready for fertilization, which induces entry into a sequence of 12 rapid, synchronous, mitotic cycles culminating in the midblastula transition. Masui and Markert  demonstrated that the progesterone signal can be bypassed by injecting immature oocytes with cytoplasm from mature oocytes, which (they opined) contained a ‘maturation promoting factor’ (MPF) that triggered the activation of a pool of inactive MPF in the immature oocyte. Later experiments by Kirschner and colleagues  showed that ‘MPF activity’ is elevated whenever frog eggs are in M phase (meiosis in oocytes or mitosis in fertilized eggs), and the acronym was reinterpreted as ‘M-phase promoting factor’.
Meanwhile, Nurse and colleagues, studying cell growth and division in fission yeast by genetic tools, had discovered three genes involved in regulating entry into mitosis: cdc2, cdc25 and wee1. The genetic evidence suggested that the cdc2 gene product, the protein Cdc2, can be either ‘inactive’ (in interphase) or ‘active’ (in mitosis). Cdc25, the product of the cdc25 gene, appeared to promote the activation of Cdc2, and Wee1 to inhibit the activation of Cdc2. Significantly, Nurse found that the length of rod-shaped fission yeast cells when they enter mitosis is sensitively dependent on the dosage of the wee1 and cdc25 genes. Deletion of wee1 makes cells smaller, whereas overexpression of wee1 makes cells larger. Deletion and overexpression of cdc25 have the opposite effects. These facts are consistent with the notion that Wee1 is an inhibitor of entry into mitosis and Cdc25 is an activator. Upon cloning these genes, Nurse and coworkers found that Cdc2 is a serine/threonine protein kinase and Wee1 is a tyrosine/threonine protein kinase. The amino acid sequence of Cdc25 was unlike any other proteins known at that time. With characteristic caution, Nurse  diagrammed the genetic evidence as in Fig. 1b, although he speculated that Wee1 inhibited Cdc2 by phosphorylating it on neighboring threonine and tyrosine residues, and Cdc25 activated Cdc2 by promoting the removal of these phosphate groups.
The activity called MPF proved particularly difficult to purify biochemically, but this feat was eventually achieved by Lohka et al. , who showed that MPF activity was associated with co-purification of Cdc2 and cyclin B [9–11]. It was thought most likely that cyclin binds to Cdc2 to form a kinase-active heterodimer (a process called ‘stoichiometric’ activation), but the possibility that cyclin played a catalytic role in the activation of Cdc2 could not be ruled out.
Two other experiments are especially relevant to our story. Mark Solomon, working in Kirschner’s lab, was studying the activation of Cdc2 by cyclin B in frog egg extracts that lacked both cyclin synthesis and cyclin degradation . Solomon supplemented these extracts with fixed concentrations of non-degradable cyclin B and measured the resultant activity of Cdc2 kinase (by its phosphorylation of a representative substrate, histone H1) as a function of cyclin B level. We shall call this a ‘signal-response’ curve: cyclin B level being the signal, and Cdc2-kinase activity being the response. Solomon found a distinct ‘cyclin threshold’ for Cdc2 activation (Fig. 1c). For cyclin concentrations less than the threshold, he observed only background levels of histone H1 phosphorylation, but as soon as the cyclin level was greater than the threshold, the extract abruptly exhibited a high rate of histone phosphorylation, which increased further with increasing cyclin concentration.
In a similar fashion, Marie-Anne Félix was studying Cdc2-induced degradation of cyclin in frog egg extracts in Karsenti’s lab . To an interphase-arrested extract (no cyclin synthesis), she added a small amount of [35S]-labeled cyclin B plus a measured amount of exogenously synthesized Cdc2:cyclin B heterodimers (i.e., MPF, measured in units of kinase activity per microliter of extract). She found that for MPF activity less than 6 U/μl, the [35S]-labeled cyclin B was only slowly degraded, but for higher concentrations of MPF (≥12 U/μl), the radioactively labeled cyclin B was rapidly degraded, after a time delay of 15 minutes or longer (Fig. 1d).
In the next section, we describe three simple mathematical models of these interactions between Cdc2 and cyclin B. The strengths and weaknesses of these models, in light of the experimental results of the time, set the stage for later, more successful models.
Based on the reaction networks in Fig. 2 (left panels), the modelers converted their biochemical assumptions about the interactions of cyclin and MPF into differential equations for the rates of change of cyclin level and MPF activity. These mathematical equations describe the expected properties of the hypothetical mitotic control system given the assumptions behind each model, and these properties can then be compared with experimental observations to assess the reliability of the model. For instance, all three models exhibit spontaneous oscillations of MPF activity similar to MPF oscillations observed in frog egg extracts and to the mitotic cycles observed in early frog embryos. MPF oscillations in each model depend, of course, on the values assigned to the rate constants peculiar to each model, as illustrated in the middle panels of Fig. 2, which shows how the amplitude of MPF oscillations depends on the rate of synthesis of cyclin B (the rate constant k s). Notice that, in each model, the rate of cyclin synthesis must be greater than a certain minimum value for MPF oscillations to appear, as observed by Murray and Kirschner .
The models differ, however, in the dependence of MPF activity on a fixed concentration of cyclin (right panels of Fig. 2), which is Solomon’s signal-response curve (Fig. 1c). The Norel/Agur model is inconsistent with Solomon’s curve because the model has no ‘upper’ steady state of high MPF activity. In Goldbeter’s model, MPF activity increases abruptly over a small range of cyclin concentrations (a phenomenon called ‘ultrasensitivity’ ). Goldbeter’s ultrasensitive signal-response curve is consistent with the abrupt rise of MPF activity observed by Solomon. However, Goldbeter’s curve has a flat plateau for cyclin concentrations greater than the threshold, whereas Solomon’s measurements show a steady rise in MPF activity for increasing cyclin concentration above the threshold. In contrast to Goldbeter’s sigmoidal signal-response curve, Tyson’s model predicts an S-shaped curve, which is also consistent with Solomon’s experimental results, provided one interprets Solomon’s ‘threshold’ with the lower turning point of the S-shaped curve. Although both Goldbeter and Tyson referred to Solomon’s paper, neither of them commented on the significance of Solomon’s ‘cyclin threshold for Cdc2 activation’ with respect to their computed ‘signal-response’ curves.
The 1991 models were simple, with two or three differential equations (one for each time-varying species) and a handful of rate constants (one or two for each biochemical reaction). However, they were of little value in providing a unified, accurate picture of what was then known about mitotic regulation in eukaryotes and in making reliable predictions. To overcome these problems would require a more careful accounting of the molecular biology and cell physiology of frog eggs and yeast cells.
The successful features of the 1993 model gave us the confidence to make some intrepid predictions.
First prediction (P1)
If MPF is indeed an S-shaped function of cyclin level, as suggested by Fig. 3b, then Solomon’s threshold reflects a discontinuous jump in MPF activity (the upward arrow in Fig. 3b), not a sigmoidal switch, as suggested by Goldbeter’s model (Fig. 2b, right panel). Consequently, if one were to start the extract in the upper steady state (the mitotic state) and decrease the cyclin concentration in stages, then one would observe a lower cyclin threshold for MPF inactivation (the discontinuous jump indicated by the downward arrow in Fig. 3b). According to our 1993 model (and Tyson’s 1991 model), there should be two different cyclin thresholds: one for flipping the switch ‘on’ at the up-arrow (Solomon’s threshold), and a lower threshold for flipping the switch ‘off’ at the down-arrow (a prediction of the model). For cyclin concentrations between the two thresholds, the switch can be either off (low MPF activity) or on (high MPF activity) depending on whether the switch started out in the off or on position. This sort of behavior — called ‘bistability’ — is familiar to anyone who has operated an old-fashion ‘snap-action’ light switch (as explained, for example, in Wikipedia), which toggles abruptly between lights on and lights off as the lever is pushed beyond the central position. When the lever is in the central position, the lights can be either on or off, depending on whether the lever is being pushed from the on position or from the off position. Our prediction that MPF activation is governed by a bistable switch differs radically from the simple interpretation of Solomon’s observations as a sigmoidal signal-response curve, for which MPF activation and inactivation occur at the same concentration of cyclin.
Second prediction (P2)
Furthermore, if Solomon’s threshold corresponds to a discontinuous transition at the turning point of an S-shaped signal-response curve, then, if the cyclin concentration is only slightly larger than the threshold, the transition is still all-or-none but the time required to make the transition is very long (a phenomenon called ‘critical slowing down’ in the field of dynamical systems). Again, these properties are not characteristic of a sigmoidal switch.
Third prediction (P3)
In addition, if MPF activation (at the interphase-to-mitosis transition) is governed by the turning point of an S-shaped curve, then the most natural explanation for checkpoint signals that delay this transition is a biochemical change that moves the turning point to larger values of total cyclin B.
Fourth predicition (P4)
The most sensitive point in the mechanism for such a signal to act is the protein phosphatase that opposes MPF in the phosphorylation of Wee1 and Cdc25. This theoretical observation suggests a possible role for regulated serine/threonine protein phosphatases in cell cycle control.
At the time we made these predictions, there were no experimental observations to suggest that our predictions were correct and plenty of reasons to doubt them. Ten years later, predictions P1–P3 were confirmed experimentally by Sha et al.  and by Pomerening et al. . Prediction P4 was not borne out by later molecular studies of checkpoint mechanisms, but regulated phosphatases, as we shall see, were found to play critical roles in other situations.
Theoreticians, especially physicists, like simple, elegant models with few parameters (four parameters supposedly suffice to ‘fit an elephant’), but living matter, it would appear, is not so simple. The 1991 models of MPF regulation were parsimonious but inaccurate and ineffectual. Effective models of mitotic control (models that can account for a wide range of important physiological features and that can make trustworthy predictions) require dozen(s) of differential equations (one for each important protein and post-translationally modified form) and an attendant proliferation of unknown rate constants. Nonetheless, we were able to show  that the model in Fig. 3a, under quite reasonable conditions, can be reduced to just two differential equations and a few control parameters. This reduced model provides the desired accurate and parsimonious picture of many characteristic features of mitotic control in frog eggs and fission yeast cells. However, to dig deeper into the molecular foundations of cell cycle control, including regulation of DNA synthesis as well as mitosis, requires the creation of more detailed dynamical models, as illustrated by our later studies of fission yeast  and budding yeast .
If we are compelled to build detailed models, then we must eventually face the problem of how to estimate dozens of unknown parameter values (rate constants, binding constants, enzyme activities, and so on). There is nothing new or unexpected about this problem; every rate constant is estimated ultimately by fitting a mechanistic model to experimental data. The more complicated the mechanism and the longer the list of unknown rate constants, the more data will be needed to estimate them. To estimate a large number of parameters, we will need reliable data that probe every aspect of the mechanism, but we do not need great quantities of data. A few data points on a time course of cyclin accumulation or disappearance may be enough to estimate the rate constant of cyclin synthesis or degradation with enough accuracy for our purposes. Indeed, we found, in fitting the 1993 model to frog egg-and-extract data, that we could estimate the important rate constants in the model with some confidence. One might consider these rate constant values as additional predictions of the model, since they were not, at the time, measured by independent biochemical investigations. Over the next few years, Kumagai, Dunphy and other biochemists, employing clever manipulations of frog egg extracts, provided direct measurements of many of the rate constants estimated by the model . Although these biochemists were unaware of our model and certainly not intending to confirm our parameter values, their measured values are very much in line with our estimates .
The interesting question now is how various molecular components collectively give rise to phenotype and physiology
Of special significance is the double-negative feedback loop between Gwl and B55, which (we propose) creates a bistable switch controlled by MPF . (Let’s call it the BEG switch, for B55-Ensa-Gwl .) As a cell enters mitosis, B55 activity is high, and high MPF activity is required to flip the BEG switch to the state of low B55 activity. Once the switch is flipped, moderate or even low activity of MPF is enough to keep B55 activity off and APC activity on (Fig. 4b). For this reason (we propose), as cells degrade cyclin B during anaphase and telophase, they do not prematurely inactivate the APC and abort cyclin B degradation. There is experimental evidence that APC activity functions as an ultrasensitive switch ; we propose that, on closer examination, APC will behave as a bistable switch (Fig. 4c) [38, 37].
If we correctly understand the role of regulated B55 in entry into and exit from mitosis, then one might reasonably ask how we could have achieved such a good description of mitotic controls in frog eggs with the 1993 model, which neglected any regulation of the MPF-counteracting phosphatase. The answer seems to lie in our choice of parameter values. In the 1993 model, we introduced a Cdc2-counteracting phosphatase (called ‘PPase’ in that paper, which we now know to be B55), and assigned it a moderate activity needed to set the limits of the bistable region (Fig. 3b) created by the interactions of MPF with Wee1 and Cdc25. Meanwhile, APC activation was controlled by a time-delay mechanism through the ‘intermediary enzyme’ IE in Fig. 3a. By adjusting the parameter values in the ‘IE-APC’ part of the network we could get APC to turn on after a time delay consistent with Félix et al.  (Fig. 3c) and to stay on long enough to degrade most of the cyclin B during the transition from metaphase to interphase. Compared to the 1993 model, the new model , with regulated B55, is parametrized differently and gives a better description (we believe) of the course of events at mitosis in frog embryos.
It is worth mentioning that the BEG switch is not essential for entry into mitosis in mammalian cells [39, 41]. In this sense, our 1993 model of frog egg extracts is actually more appropriate as a model of mammalian cells than of frog eggs, for which it was intended. Or we might say it is a model of frog eggs with constitutively phosphorylated Gwl.
The BEG mechanism was discovered because it is essential for mitotic entry in frog egg extracts [36, 42]. If Gwl and/or Ensa are depleted from extracts, then nuclei are blocked in late interphase (with replicated DNA). Why, we might ask, is Ensa essential in embryos but not in somatic cells? Recall that immature oocytes must arrest in G2 phase of meiosis I, awaiting a hormonal signal to undergo maturation. In this state, they may accumulate very high levels of preMPF, but they must not enter meiotic M phase prematurely. Having a high level of PP2A:B55δ could be a fail-safe mechanism for stabilizing the arrested oocyte. But in this case, B55 activity must be down-regulated in meiosis I in order for the egg to proceed into meiosis II, which might be the role of Gwl and Ensa.
In our experience, mathematical modeling has been an effective tool for investigating alternative hypotheses about the molecular mechanisms controlling the cell division cycle. The models showed how positive and negative feedback loops in the cyclin-MPF control system create toggle switches and oscillators that are crucial to the temporal sequencing of cell cycle events. Our 1993 model made many non-intuitive predictions about MPF activation in frog egg extracts, as described earlier. Later models of cell cycle controls in fission yeast [20, 23] and budding yeast  provided detailed accounts of the idiosyncratic phenotypes exhibited by mutant yeast strains, and suggested a new way to understand the irreversibility of cell cycle transitions in terms of bistable signal-response curves . In most cases, the predictions of the models have been fully confirmed by subsequent experiments, as summarized in .
In general terms, building a model forces the modeler to lay out his or her assumptions clearly; analyzing and simulating the model determines the logical implications of these assumptions; and comparing the conclusions to experimental facts assesses the explanatory and predictive power of the mechanistic hypothesis. Where the conclusions of the model diverge from experimental facts may suggest problems with the ‘working hypotheses’ or missing components in the mechanism.
If mathematical modeling is such a nifty tool, why has it taken so long for molecular biologists to incorporate it into their armamentarium? In our experience, mathematical modeling of the cell cycle was at first politely ignored, then actively opposed, and lately grudgingly accepted. Perhaps this is to be expected of any new approach that is unusual and difficult to employ. But most people are comfortable now with the realization that molecular cell biology is a complex, interdisciplinary field that requires expertise from many quarters: genetics, biochemistry, nanotechnology, image processing, and bioinformatics, for example. Modern biological research is team-based, and, where appropriate, these teams need expertise in mathematical modeling of molecular regulatory networks. This is a specialized skill, much like X-ray crystallography, molecular genetics, proteomics or super-resolution microscopy. Life science departments need to acknowledge the vital role of models in biology and hire computational biologists who can bring this tool to bear on the important and difficult problems of today and tomorrow.
Our research on cell cycle regulation has been supported generously by the National Science Foundation (DMS-1225160) and the National Institutes of Health (R01-GM078989, Ro1-GM095955) of the USA to JJT and by EC’s Seventh Framework Programme (MitoSys/241548) and BBSRC Strategic LoLa grant (BB/MM00354X/1) to BN.
- Gunawardena J. Models in biology: 'accurate descriptions of our pathetic thinking'. BMC Biol. 2014;12:29. doi:10.1186/1741-7007-12-29.PubMed CentralPubMedView ArticleGoogle Scholar
- Murray AW, Kirschner MW. Dominoes and clocks: the union of two views of the cell cycle. Science. 1989;246:614–21.PubMedView ArticleGoogle Scholar
- Nurse P. Universal control mechanism regulating onset of M-phase. Nature. 1990;344:503–8.PubMedView ArticleGoogle Scholar
- Masui Y, Markert CL. Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J Exp Zool. 1971;177:129–45.PubMedView ArticleGoogle Scholar
- Gerhart J, Wu M, Kirschner M. Cell cycle dynamics of an M-phase-specific cytoplasmic factor in Xenopus laevis oocytes and eggs. J Cell Biol. 1984;98:1247–55.PubMedView ArticleGoogle Scholar
- Murray AW, Kirschner MW. Cyclin synthesis drives the early embryonic cell cycle. Nature. 1989;339:275–80.PubMedView ArticleGoogle Scholar
- Murray AW, Solomon MJ, Kirschner MW. The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature. 1989;339:280–6.PubMedView ArticleGoogle Scholar
- Lohka MJ, Hayes MK, Maller JL. Purification of maturation-promoting factor, an intracellular regulator of early mitotic events. Proc Natl Acad Sci U S A. 1988;85:3009–13.PubMed CentralPubMedView ArticleGoogle Scholar
- Gautier J, Minshull J, Lohka M, Glotzer M, Hunt T, Maller JL. Cyclin is a component of maturation-promoting factor from Xenopus. Cell. 1990;60:487–94.PubMedView ArticleGoogle Scholar
- Gautier J, Norbury C, Lohka M, Nurse P, Maller J. Purified maturation-promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene cdc2+. Cell. 1988;54:433–9.PubMedView ArticleGoogle Scholar
- Dunphy WG, Brizuela L, Beach D, Newport J. The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell. 1988;54:423–31.PubMedView ArticleGoogle Scholar
- Solomon MJ, Glotzer M, Lee TH, Philippe M, Kirschner MW. Cyclin activation of p34cdc2. Cell. 1990;63:1013–24.PubMedView ArticleGoogle Scholar
- Felix MA, Labbe JC, Doree M, Hunt T, Karsenti E. Triggering of cyclin degradation in interphase extracts of amphibian eggs by cdc2 kinase. Nature. 1990;346:379–82. doi:10.1038/346379a0.PubMedView ArticleGoogle Scholar
- Norel R, Agur Z. A model for the adjustment of the mitotic clock by cyclin and MPF levels. Science. 1991;251:1076–8.PubMedView ArticleGoogle Scholar
- Goldbeter A. A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase. Proc Natl Acad Sci U S A. 1991;88:9107–11.PubMed CentralPubMedView ArticleGoogle Scholar
- Tyson JJ. Modeling the cell division cycle: cdc2 and cyclin interactions. Proc Natl Acad Sci U S A. 1991;88:7328–32.PubMed CentralPubMedView ArticleGoogle Scholar
- Goldbeter A, Koshland Jr DE. An amplified sensitivity arising from covalent modification in biological systems. Proc Natl Acad Sci U S A. 1981;78:6840–4.PubMed CentralPubMedView ArticleGoogle Scholar
- Novak B, Tyson JJ. Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J Cell Sci. 1993;106:1153–68.PubMedGoogle Scholar
- Novak B, Tyson JJ. Modeling the cell division cycle: M-phase trigger, oscillations and size control. J Theor Biol. 1993;165:101–34.View ArticleGoogle Scholar
- Novak B, Tyson JJ. Quantitative analysis of a molecular model of mitotic control in fission yeast. J Theor Biol. 1995;173:283–305.View ArticleGoogle Scholar
- Sha W, Moore J, Chen K, Lassaletta AD, Yi CS, Tyson JJ, et al. Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts. Proc Natl Acad Sci U S A. 2003;100:975–80.PubMed CentralPubMedView ArticleGoogle Scholar
- Pomerening JR, Sontag ED, Ferrell Jr JE. Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat Cell Biol. 2003;5:346–51.PubMedView ArticleGoogle Scholar
- Novak B, Tyson JJ. Modeling the control of DNA replication in fission yeast. Proc Natl Acad Sci U S A. 1997;94:9147–52.PubMed CentralPubMedView ArticleGoogle Scholar
- Chen KC, Csikasz-Nagy A, Gyorffy B, Val J, Novak B, Tyson JJ. Kinetic analysis of a molecular model of the budding yeast cell cycle. Mol Biol Cell. 2000;11:369–91.PubMed CentralPubMedView ArticleGoogle Scholar
- Kumagai A, Dunphy WG. Control of the Cdc2/cyclin B complex in Xenopus egg extracts arrested at a G2/M checkpoint with DNA synthesis inhibitors. Mol Biol Cell. 1995;6:199–213.PubMed CentralPubMedView ArticleGoogle Scholar
- Marlovits G, Tyson CJ, Novak B, Tyson JJ. Modeling M-phase control in Xenopus oocyte extracts: the surveillance mechanism for unreplicated DNA. Biophys Chem. 1998;72:169–84.PubMedView ArticleGoogle Scholar
- Novak B, Tyson JJ, Gyorffy B, Csikasz-Nagy A. Irreversible cell-cycle transitions are due to systems-level feedback. Nat Cell Biol. 2007;9:724–8.PubMedView ArticleGoogle Scholar
- Cross FR, Archambault V, Miller M, Klovstad M. Testing a mathematical model of the yeast cell cycle. Mol Biol Cell. 2002;13:52–70.PubMed CentralPubMedView ArticleGoogle Scholar
- Lopez-Aviles S, Kapuy O, Novak B, Uhlmann F. Irreversibility of mitotic exit is the consequence of systems-level feedback. Nature. 2009;459:592–5.PubMed CentralPubMedView ArticleGoogle Scholar
- Mirchenko L, Uhlmann F. Sli15(INCENP) dephosphorylation prevents mitotic checkpoint reengagement due to loss of tension at anaphase onset. Curr Biol. 2010;20:1396–401.PubMed CentralPubMedView ArticleGoogle Scholar
- Oliveira RA, Hamilton RS, Pauli A, Davis I, Nasmyth K. Cohesin cleavage and Cdk inhibition trigger formation of daughter nuclei. Nat Cell Biol. 2010;12:185–92.PubMed CentralPubMedView ArticleGoogle Scholar
- Haskins EF. Stemonitis flavogenita (Myxomycetes) plasmodial phase (aphanoplasmodium). In: Institut Wissenschaftlichen Film. Göttingen: Film E; 2000. 1974.Google Scholar
- Chang JB, Ferrell Jr JE. Mitotic trigger waves and the spatial coordination of the Xenopus cell cycle. Nature. 2013;500:603–7. doi:10.1038/nature12321.PubMed CentralPubMedView ArticleGoogle Scholar
- Mochida S, Maslen SL, Skehel M, Hunt T. Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science. 2010;330:1670–3.PubMedView ArticleGoogle Scholar
- Gharbi-Ayachi A, Labbe JC, Burgess A, Vigneron S, Strub JM, Brioudes E, et al. The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science. 2010;330:1673–7.PubMedView ArticleGoogle Scholar
- Yu J, Zhao Y, Li Z, Galas S, Goldberg ML. Greatwall kinase participates in the Cdc2 autoregulatory loop in Xenopus egg extracts. Mol Cell. 2006;22:83–91.PubMedView ArticleGoogle Scholar
- Vernieri C, Chiroli E, Francia V, Gross F, Ciliberto A. Adaptation to the spindle checkpoint is regulated by the interplay between Cdc28/Clbs and PP2ACdc55. J Cell Biol. 2013;202:765–78. doi:10.1083/jcb.201303033.PubMed CentralPubMedView ArticleGoogle Scholar
- Zhang T, Tyson JJ, Novak B. Role for regulated phosphatase activity in generating mitotic oscillations in Xenopus cell-free extracts. Proc Natl Acad Sci U S A. 2013;110:20539–44. doi:10.1073/pnas.1318065110.PubMed CentralPubMedView ArticleGoogle Scholar
- Cundell MJ, Bastos RN, Zhang T, Holder J, Gruneberg U, Novak B, et al. The BEG (PP2A-B55/ENSA/Greatwall) pathway ensures cytokinesis follows chromosome separation. Mol Cell. 2013;52:393–405. doi:10.1016/j.molcel.2013.09.005.PubMed CentralPubMedView ArticleGoogle Scholar
- Yang Q, Ferrell Jr JE. The Cdk1-APC/C cell cycle oscillator circuit functions as a time-delayed, ultrasensitive switch. Nat Cell Biol. 2013;15:519–25. doi:10.1038/ncb2737.PubMed CentralPubMedView ArticleGoogle Scholar
- Alvarez-Fernandez M, Sanchez-Martinez R, Sanz-Castillo B, Gan PP, Sanz-Flores M, Trakala M, et al. Greatwall is essential to prevent mitotic collapse after nuclear envelope breakdown in mammals. Proc Natl Acad Sci U S A. 2013;110:17374–9. doi:10.1073/pnas.1310745110.PubMed CentralPubMedView ArticleGoogle Scholar
- Vigneron S, Brioudes E, Burgess A, Labbe JC, Lorca T, Castro A. Greatwall maintains mitosis through regulation of PP2A. EMBO J. 2009;28:2786–93.PubMed CentralPubMedView ArticleGoogle Scholar
- Tyson JJ, Novak B. Bistability, oscillations, and traveling waves in frog egg extracts. Bull Math Biol. 2015;77:796–816. doi:10.1007/s11538-014-0009-9.PubMedView ArticleGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.